Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS
By connecting patients, pharmacists, caregivers, and providers, the PMAS delivers patient care in a decentralized format
SANTA CLARA, Calif. — December 5, 2018 — Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Philips, a global leader in health technology, with the 2018 North American Enabling Technology Leadership Award for creating a connected ecosystem that allows payers and providers to track their patients’ health. The Philips Medication Adherence Solution (PMAS) features spencer®, an enterprise-grade medication dispenser, which finds special application in managing medication for high acuity and chronic disease patients. With this solution, pharmacists, caregivers, patients, and providers are connected on a single platform, making it a vastly superior solution to mere pill dispensing devices.
“The PMAS eases traceability and follow-ups, and supports patients’ compliance with treatment protocols. It is designed with a patient-friendly interface, as well as an alert system and connected app that offers timely notifications for pharmacists and clinicians if a patient misses a dose,” said Divyaa Ravishankar Industry Principal. “With its remote patient monitoring capability, digital tools, and door-to-door delivery, the company has innovated the caregiving pathway from hospital to home.”
The World Health Organization (WHO) requires a patient’s compliance to be at 80 percent, but the PMAS has an average patient adherence level of 98 percent. Many long-term care centers in the United States use spencer® to help elderly and chronically ill patients better manage their health. The solution enables the patient’s caregivers to keep close watch on their adherence, as its automated dispensing service is linked to the phone line and issues alerts to caregivers. Additionally, the device can even function during power outages, dispense medication in advance if a patient is scheduled to travel, and set both audio and visual reminders to ensure no doses are missed.
Providers contracted by Philips offer PMAS units to their patients at no direct cost, and every spencer®-certified pharmacist verifies coverage details before transferring and packaging prescriptions to the device. One of the most significant value-added features in the device is the spencer® Assist app, which facilitates information sharing between patients and their family caregivers. It ensures stability and transparency for high-acuity patients and is one of the best tools to monitor patients suffering from opioid addiction.
“At an enterprise level, the device can potentially improve the Medicare STAR rating for health systems,” noted Ravishankar. “By boosting medication adherence, the PMAS reduces unnecessary hospitalizations and helps all stakeholders save healthcare costs. Its 4x doses per day and provision of a subscription model have positioned it ahead of its competitors and made Philips richly deserving of the 2018 North American Enabling Technology Leadership Award.”
Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products, but also enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.
Contact:
Claudia Toscano
P: 210.477.8417
F: 210.348.100
E: claudia.toscano@frost.com
